The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - AstraZeneca; Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Patents, Royalties, Other Intellectual Property - Foundation Medicine
Complete clearance of plasma EGFR mutations as a predictor of outcome on osimertinib in the AURA trial.
 
Kenneth Stephen Thress
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Aleksandra Markovets
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
J Carl Barrett
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Juliann Chmielecki
No Relationships to Disclose
 
Sarah B. Goldberg
Research Funding - AstraZeneca; Clovis Oncology (Inst); Genentech (Inst); Immunogen (Inst); Kadmon (Inst); Merck (Inst)
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck Serono; Merck Sharp & Dohme; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; Merck Serono
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Lilly (Inst); Merrimack (Inst); Pfizer (Inst); Roche Canada (Inst)
 
Sarah Vowler
Employment - AstraZeneca
 
Geoffrey R. Oxnard
Honoraria - AstraZeneca; Chugai Pharma
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Genentech/Roche; Inivata; Sysmex; Takeda
Patents, Royalties, Other Intellectual Property - DFCI has a patent pending titled "Non-invasive blood-based monitoring of genomic alterations in cancer", on which I am a co-author. (Inst)